Manfred Wargenau

962 total citations
34 papers, 669 citations indexed

About

Manfred Wargenau is a scholar working on Pediatrics, Perinatology and Child Health, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Manfred Wargenau has authored 34 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 8 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Manfred Wargenau's work include Pharmaceutical studies and practices (9 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Gastrointestinal motility and disorders (4 papers). Manfred Wargenau is often cited by papers focused on Pharmaceutical studies and practices (9 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Gastrointestinal motility and disorders (4 papers). Manfred Wargenau collaborates with scholars based in Germany, Switzerland and Austria. Manfred Wargenau's co-authors include Frank Bepperling, Cornelius Jungheinrich, Jan Schulze, M Hanefeld, Sabine Fischer, M. Spengler, K. Fücker, Jean‐François Baron, Henning Blume and E. Brendel and has published in prestigious journals such as Gastroenterology, Diabetes Care and European Heart Journal.

In The Last Decade

Manfred Wargenau

32 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manfred Wargenau Germany 13 151 144 141 139 83 34 669
Emuri Abé France 13 212 1.4× 222 1.5× 103 0.7× 71 0.5× 123 1.5× 45 860
Vincent F. Mauro United States 16 45 0.3× 242 1.7× 17 0.1× 173 1.2× 80 1.0× 45 735
Robert M. Stote United States 14 93 0.6× 107 0.7× 11 0.1× 80 0.6× 122 1.5× 25 702
Şükrü Ulusoy Türkiye 16 59 0.4× 108 0.8× 18 0.1× 126 0.9× 109 1.3× 66 746
H.-H. Neumayer Germany 18 63 0.4× 286 2.0× 23 0.2× 223 1.6× 208 2.5× 43 1.3k
Xiao‐cong Zuo China 16 62 0.4× 82 0.6× 22 0.2× 64 0.5× 130 1.6× 59 929
E. McClean United Kingdom 15 37 0.2× 262 1.8× 36 0.3× 120 0.9× 65 0.8× 32 943
Raymond Vanholder Belgium 11 150 1.0× 304 2.1× 48 0.3× 64 0.5× 288 3.5× 14 1.3k
Lyle A. Siddoway United States 15 26 0.2× 97 0.7× 49 0.3× 559 4.0× 221 2.7× 25 1.1k
Parviz Khajehdehi Iran 15 148 1.0× 89 0.6× 39 0.3× 60 0.4× 127 1.5× 31 885

Countries citing papers authored by Manfred Wargenau

Since Specialization
Citations

This map shows the geographic impact of Manfred Wargenau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Wargenau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Wargenau more than expected).

Fields of papers citing papers by Manfred Wargenau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Wargenau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Wargenau. The network helps show where Manfred Wargenau may publish in the future.

Co-authorship network of co-authors of Manfred Wargenau

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Wargenau. A scholar is included among the top collaborators of Manfred Wargenau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Wargenau. Manfred Wargenau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Zhendong, Max Taubert, Chunli Chen, et al.. (2024). A Semi-Mechanistic Population Pharmacokinetic Model of Noscapine in Healthy Subjects Considering Hepatic First-Pass Extraction and CYP2C9 Genotypes. Drugs in R&D. 24(2). 187–199. 1 indexed citations
2.
3.
4.
Andresen, Viola, et al.. (2024). Efficacy and Safety of STW 5-II for Functional Dyspepsia Treatment: A Patient Data-Based Meta-Analysis. Digestion. 105(3). 166–174. 8 indexed citations
5.
6.
Wargenau, Manfred, et al.. (2022). A Composite Endpoint for Acceptability Evaluation of Oral Drug Formulations in the Pediatric Population. Therapeutic Innovation & Regulatory Science. 56(6). 903–909. 11 indexed citations
7.
Schön, Christiane, et al.. (2018). Blood glucose response after oral intake of lactulose in healthy volunteers: A randomized, controlled, cross-over study. World Journal of Gastrointestinal Pharmacology and Therapeutics. 9(3). 22–30. 9 indexed citations
8.
9.
Mascherbauer, Julia, Ekkehard Grünig, Michael Halank, et al.. (2016). Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction. Wiener klinische Wochenschrift. 128(23-24). 882–889. 20 indexed citations
10.
Queckenberg, Christian, et al.. (2015). Pharmacokinetics and pharmacogenetics of capecitabine and its metabolites following replicate administration of two 500 mg tablet formulations. Cancer Chemotherapy and Pharmacology. 76(5). 1081–1091. 14 indexed citations
11.
12.
Yamakage, Michiaki, Frank Bepperling, Manfred Wargenau, & Hideki Miyao. (2012). Pharmacokinetics and safety of 6 % hydroxyethyl starch 130/0.4 in healthy male volunteers of Japanese ethnicity after single infusion of 500 ml solution. Journal of Anesthesia. 26(6). 851–857. 8 indexed citations
13.
Gutmann, A., et al.. (2005). Propofol anesthesia in spontaneously breathing children undergoing magnetic resonance imaging: comparison of two propofol emulsions. Pediatric Anesthesia. 16(3). 266–274. 12 indexed citations
14.
Schug, Barbara, et al.. (2002). Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union. European Journal of Pharmaceutical Sciences. 15(3). 279–285. 47 indexed citations
15.
Jungheinrich, Cornelius, et al.. (2002). The Pharmacokinetics and Tolerability of an Intravenous Infusion of the New Hydroxyethyl Starch 130/0.4 (6%, 500 mL) in Mild-to-Severe Renal Impairment. Anesthesia & Analgesia. 95(3). 544–551. 101 indexed citations
16.
Schug, Barbara, E. Brendel, Meinolf Wonnemann, et al.. (2002). Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast. European Journal of Clinical Pharmacology. 58(2). 119–125. 38 indexed citations
17.
Kierdorf, Horst, A. M�ller, Philipp Blanke, et al.. (1993). Pharmacodynamics and pharmacokinetics of oral nitrendipine solution in hypertensive patients with advanced renal failure. European Journal of Clinical Pharmacology. 45(2). 129–134. 4 indexed citations
18.
Cupissol, Didier, James Carmichael, E.M. Bessell, et al.. (1993). Evaluation of the Bioequivalence of Tablet and Capsule Formulations of Granisetron in Patients Undergoing Cytotoxic Chemotherapy for Malignant Disease. Journal of Pharmaceutical Sciences. 82(12). 1281–1284. 14 indexed citations
19.
Schaefer, Hans, et al.. (1993). Effect of food on the pharmacokinetics of the active metabolite of the prodrug repirinast. Journal of Pharmaceutical Sciences. 82(1). 107–109. 4 indexed citations
20.
Beermann, D., et al.. (1992). Pharmacokinetics of the active metabolite of the prodrug repirinast in healthy Caucasian volunteers after a single oral dose. European Journal of Clinical Pharmacology. 42(3). 307–12. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emuri Abé Breakdown of academic impact, for papers by Vincent F. Mauro Breakdown of academic impact, for papers by Robert M. Stote Breakdown of academic impact, for papers by Şükrü Ulusoy Breakdown of academic impact, for papers by H.-H. Neumayer Breakdown of academic impact, for papers by Xiao‐cong Zuo Breakdown of academic impact, for papers by E. McClean Breakdown of academic impact, for papers by Raymond Vanholder Breakdown of academic impact, for papers by Lyle A. Siddoway Breakdown of academic impact, for papers by Parviz Khajehdehi
Rankless by CCL
2026